JPH11512107A5 - - Google Patents

Info

Publication number
JPH11512107A5
JPH11512107A5 JP1997510839A JP51083997A JPH11512107A5 JP H11512107 A5 JPH11512107 A5 JP H11512107A5 JP 1997510839 A JP1997510839 A JP 1997510839A JP 51083997 A JP51083997 A JP 51083997A JP H11512107 A5 JPH11512107 A5 JP H11512107A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997510839A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11512107A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1996/003814 external-priority patent/WO1997009048A1/en
Publication of JPH11512107A publication Critical patent/JPH11512107A/ja
Publication of JPH11512107A5 publication Critical patent/JPH11512107A5/ja
Ceased legal-status Critical Current

Links

JP9510839A 1995-09-09 1996-08-30 チエノトリアゾロジアゼピンのアポリポタンパク質a−iレベル増加のための用途 Ceased JPH11512107A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95114163 1995-09-09
EP95114163.9 1995-09-09
PCT/EP1996/003814 WO1997009048A1 (en) 1995-09-09 1996-08-30 Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels

Publications (2)

Publication Number Publication Date
JPH11512107A JPH11512107A (ja) 1999-10-19
JPH11512107A5 true JPH11512107A5 (cg-RX-API-DMAC10.html) 2004-08-12

Family

ID=8219597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9510839A Ceased JPH11512107A (ja) 1995-09-09 1996-08-30 チエノトリアゾロジアゼピンのアポリポタンパク質a−iレベル増加のための用途

Country Status (14)

Country Link
US (1) US5854238A (cg-RX-API-DMAC10.html)
EP (1) EP0853480B1 (cg-RX-API-DMAC10.html)
JP (1) JPH11512107A (cg-RX-API-DMAC10.html)
KR (1) KR19990044460A (cg-RX-API-DMAC10.html)
CN (1) CN1101680C (cg-RX-API-DMAC10.html)
AT (1) ATE230600T1 (cg-RX-API-DMAC10.html)
AU (1) AU725249B2 (cg-RX-API-DMAC10.html)
BR (1) BR9610390A (cg-RX-API-DMAC10.html)
CA (1) CA2230477A1 (cg-RX-API-DMAC10.html)
DE (1) DE69625696T2 (cg-RX-API-DMAC10.html)
DK (1) DK0853480T3 (cg-RX-API-DMAC10.html)
ES (1) ES2188783T3 (cg-RX-API-DMAC10.html)
TR (1) TR199800406T1 (cg-RX-API-DMAC10.html)
WO (1) WO1997009048A1 (cg-RX-API-DMAC10.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518412B1 (en) * 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) * 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6253569B1 (en) * 1999-05-07 2001-07-03 James J. Hall Portable storage unit for game animals
US7723303B2 (en) 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US7166578B2 (en) 2000-08-24 2007-01-23 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7199102B2 (en) * 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7144862B2 (en) 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US8124625B2 (en) 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US20040235877A1 (en) 2001-09-14 2004-11-25 Natsuki Ishizuka Novel use of tricyclic compound
US6930085B2 (en) 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
KR20070089996A (ko) 2004-12-06 2007-09-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 세동맥의 구조 및 기능의 개선 방법
JP2010538005A (ja) 2007-08-28 2010-12-09 ユーエービー リサーチ ファウンデーション 合成アポリポ蛋白質e模倣ポリペプチドおよび使用方法
AU2008296487A1 (en) 2007-08-28 2009-03-12 The Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
CN102292341B (zh) * 2008-10-30 2014-09-10 环行医学有限责任公司 对apo a有活性的噻吩并三唑并二氮杂*衍生物
CN103154246B (zh) 2010-05-14 2015-11-25 达那-法伯癌症研究所 用于治疗白血病的组合物和方法
ES2606958T3 (es) 2010-05-14 2017-03-28 Dana-Farber Cancer Institute, Inc. Compuestos de tienotriazolodiazepina para tratar una neoplasia
WO2011143651A1 (en) * 2010-05-14 2011-11-17 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating metabolism
CN103180318B (zh) 2010-05-14 2017-05-10 达那-法伯癌症研究所 雄性避孕组合物以及使用方法
BR112016001457A2 (pt) 2013-07-25 2017-08-29 Dana Farber Cancer Inst Inc Inibidores de fatores de transcrição e usos dos mesmos
US11446309B2 (en) 2013-11-08 2022-09-20 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
EP3099693A4 (en) 2014-01-31 2017-08-16 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
MX2016009974A (es) 2014-01-31 2016-10-31 Dana Farber Cancer Inst Inc Derivados de diaminopirimidina bencensulfona y sus usos.
WO2015131113A1 (en) 2014-02-28 2015-09-03 Tensha Therapeutics, Inc. Treatment of conditions associated with hyperinsulinaemia
JP7081923B2 (ja) 2014-07-31 2022-06-07 ユーエイビー リサーチ ファンデーション アポe模倣ペプチド及び血漿コレステロールを取り除くためのより高い効果
WO2016022970A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
RU2017104897A (ru) 2014-08-08 2018-09-10 Дана-Фарбер Кэнсер Инститьют, Инк. Производные диазепана и их применения
UA122130C2 (uk) 2014-10-27 2020-09-25 Тенша Терапеутікс, Інк. Інгібітори бромодомену
CA2986441A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
RU2018112953A (ru) 2015-09-11 2019-10-14 Дана-Фарбер Кэнсер Инститьют, Инк. Ацетамидтиенотриазолодиазепины и пути их применения
US11306105B2 (en) 2015-09-11 2022-04-19 Dana-Farber Cancer Institute, Inc. Cyano thienotriazolodiazepines and uses thereof
CR20180336A (es) 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc Inhibidores de bromodominio bivalentes y usos de los mismos
EA202092635A1 (ru) 2018-06-13 2021-03-23 Дибли Аг Получение конденсированных производных триазепина и их применение в качестве ингибиторов bet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12303A (en) * 1973-02-08 1979-01-16 Hoffmann La Roche Thienotriazolodiazepine derivatives
US4155913A (en) * 1973-02-08 1979-05-22 Hoffmann-La Roche Inc. Thienotriazolodiazepine derivatives
JPS50100096A (cg-RX-API-DMAC10.html) * 1974-01-08 1975-08-08

Similar Documents

Publication Publication Date Title
JP2000500228A5 (cg-RX-API-DMAC10.html)
JP2000500033A5 (cg-RX-API-DMAC10.html)
JP2000500445A5 (cg-RX-API-DMAC10.html)
JP2000500440A5 (cg-RX-API-DMAC10.html)
JP2000500327A5 (cg-RX-API-DMAC10.html)
JPH11501590A5 (cg-RX-API-DMAC10.html)
JP2000500155A5 (cg-RX-API-DMAC10.html)
JP2000500406A5 (cg-RX-API-DMAC10.html)
JP2000500361A5 (cg-RX-API-DMAC10.html)
JP2000500115A5 (cg-RX-API-DMAC10.html)
JP2000500322A5 (cg-RX-API-DMAC10.html)
JP2000500258A5 (cg-RX-API-DMAC10.html)
JP2000500342A5 (cg-RX-API-DMAC10.html)
JPH11510414A5 (cg-RX-API-DMAC10.html)
JP2000500112A5 (cg-RX-API-DMAC10.html)
JP2000500166A5 (cg-RX-API-DMAC10.html)
JP2000500051A5 (cg-RX-API-DMAC10.html)
JP2000500397A5 (cg-RX-API-DMAC10.html)
JP2000500407A5 (cg-RX-API-DMAC10.html)
JP2000500019A5 (cg-RX-API-DMAC10.html)
JP2000500044A5 (cg-RX-API-DMAC10.html)
JP2000500346A5 (cg-RX-API-DMAC10.html)
JP2000500090A5 (cg-RX-API-DMAC10.html)
JP2000500257A5 (cg-RX-API-DMAC10.html)
JP2000500429A5 (cg-RX-API-DMAC10.html)